secwatch.observer — SEC 8-K summary
======================================

Issuer:     CDT Equity Inc. (CDT)
CIK:        0001896212
Form:       8-K
Filed at:   2024-11-01T23:59:59+00:00
Accession:  0001493152-24-043330
Event type: debt
Sentiment:  negative
Materiality: 0.65
Item codes: 1.01, 1.02, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Conduit Pharmaceuticals secures $1.2M in new loans; issues warrants and amends existing debt
--------------------------------------------------------------------------------

- Entered Bridge Loan with A.G.P. for up to $600k at 4.21% due Dec 31, 2024; issued warrants for 2.86M shares at $0.1048 per share, subject to shareholder approval.
- Issued $600k promissory note to Nirland Limited at 12% per annum, maturing Oct 31, 2025; includes 1% arrangement fee.
- Amended prior $2.65M Nirland note to allow conversion to common stock and removed mandatory prepayment and right of first refusal.
- Proceeds from ATM offering of up to ~$3.5M will be used first to repay the A.G.P. Bridge Note.
- Warrants and conversion shares are unregistered, issued under Section 4(a)(2) exemption.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1896212/000149315224043330/0001493152-24-043330-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1896212/000149315224043330/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-043330

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer